Trial Profile
A Phase 1, Single Centre, Single-Blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZD7687 After Administration of Multiple Ascending Doses in Overweight to Obese But Otherwise Healthy Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs AZD 7687 (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker
- 25 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 01 Apr 2011 Actual end date (1 Mar 2011) added as reported by ClinicalTrials.gov.
- 01 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.